Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Zogenix Inc. : Trading of Zogenix Common Stock Halted

12/07/2012 | 08:00am US/Eastern
Recommend:
0

FDA Advisory Committee Reviewing Zohydro™ ER New Drug Application

Zogenix to Host Conference Call at 6:30 pm ET Today

SAN DIEGO, Dec. 7, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, announced that NASDAQ halted trading of the company's common stock on December 7, 2012. The U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) is meeting today to review the Company's New Drug Application (NDA) for Zohydro™ ER (hydrocodone bitartrate extended-release capsules).

Conference Call & Webcast

Zogenix will host a conference call to discuss the outcome of the AADPAC meeting today, Friday, December 7, 2012 at 6:30 p.m. ET (3:30 p.m. PT). To participate, please dial (800) 299-9086 (U.S.) or (617) 786-2903 (International); participant passcode: 21970283. To access the live webcast please visit the Zogenix Investor Relations website at http://ir.zogenix.com.  

The conference call will be hosted by Chief Executive Officer Roger L. Hawley and President and Chief Operating Officer Stephen J. Farr, Ph.D.

A replay of the conference call will be available beginning December 7, 2012 at 8:30 p.m. ET (5:30 p.m. PT) until December 14, 2012, by dialing (888) 286-8010 (U.S.) or (617) 801-6888 (International); passcode: 27116437. A replay of the webcast will also be accessible on the Investor Relations website for one month, through January 10, 2013.

About Anesthetic and Analgesic Drug Products Advisory Committee

The AADPAC reviews and evaluates available data concerning the safety and effectiveness of marketed and investigational human anesthetic and analgesic drug products and makes appropriate recommendations to the Commissioner of Food and Drugs. The AADPAC provides FDA with independent expert advice and recommendations, however, the final decision regarding approval is made by FDA.

About Zogenix

Zogenix, Inc., with offices in San Diego and Emeryville, California, is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. Zogenix's first commercial product, SUMAVEL® DosePro® (sumatriptan injection) Needle-free Delivery System, was launched in January 2010 for the acute treatment of migraine and cluster headache. Zogenix's lead investigational product candidate, ZohydroTM ER (hydrocodone bitartrate) is an oral, novel extended-release formulation of various strengths of hydrocodone without acetaminophen intended for administration every 12 hours for around the clock management of moderate to severe chronic pain. Zogenix's second DosePro investigational product candidate, ReldayTM, is a proprietary, long-acting injectable formulation of risperidone for the treatment of schizophrenia. In May 2012, Zogenix submitted to the FDA a New Drug Application for Zohydro ER and an Investigational New Drug Application for Relday. The FDA assigned a PDUFA target action date of March 1, 2013 for the Zohydro ER NDA.

For additional information, please visit www.zogenix.com.

SUMAVEL ®, DosePro ®, ReldayTM and ZohydroTM ER are trademarks of Zogenix, Inc.

CONTACT: INVESTORS:
         Zack Kubow | The Ruth Group
         646.536.7020 | zkubow@theruthgroup.com

         MEDIA:
         Emily Poe | WCG
         212.301.7183 | epoe@wcgworld.com
Zogenix
distributed by
Recommend :
0
React to this article
Latest news
Date Title
3m ago Frankfort Chiropractor Explains Link Between Nutrition and Chronic Health Conditions
3m ago Lindenhurst Chiropractor Launches Nutrition Website
6m ago DEEP WELL OIL & GAS : Updates Shareholders on Sawn Lake Heavy Oil Project
13m ago STATOIL ASA : It's all about transparency
21m ago CHINESE PEOPLE : China marks 65th anniversary of political advisory body
33m ago T A T TECHNOLOGIES : TAT Technologies Wholly Owned Subsidiary, Piedmont Aviation Component Services has Signed a Seven Year Landing Gear Maintenance Support Agreement With Republic Airways Holdings, Inc.; the Total Value of the Agreement may Reach up to $45 Million
41m ago Zima selection criteria flawed
42m ago VOLVO : $38,953 Federal Contract Awarded to Tri-State Truck & Equipment
42m ago ISSC TECHNOLOGIES : MILITARY $201,283 Federal Contract Awarded toM.C. Dean
42m ago CISCO SYSTEMS : $212,450 Federal Contract Awarded to Red River Computer
Latest news
Advertisement
Hot News 
BANCO ESPIRITO SANTO : Swiss begin bankruptcy proceedings against Espirito Santo private bank
DIXONS CARPHONE : Phones 4U says Vodafone will take 140 of its stores
ALIBABA : CORRECTING and REPLACING Alibaba Group Announces Pricing of Initial Public Offering
EREDENE CAPITAL : Sells Aboyne To Brick Eagle For GBP3 Million
ITT EDUCATIONAL SERVICES : Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Most Read News
1d ago FORD MOTOR : Engines for Sale Now Include Lower Priced Ford and Chevy Blocks at Parts Retailer Website
1d ago SCHERZER : Shields outpitched by Scherzer, Royals fall to Tigers in AL Central matchup
1d ago ALERE : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Alere Inc. Stockholders
1d ago SRT® Motorsports Earns Three Wins and Pair of Podium One-Two Finishes in Banner Weekend
1h ago ROYAL BANK OF SCOTLAND : Relief over Scotland gives way to 'Great Stagnation' worries
Most recommended articles
1h ago Julius Baer eyes Coutts international arm, wary of bidding war
1h ago French and German visions for Europe to clash in Berlin
1h ago ROYAL BANK OF SCOTLAND : Relief over Scotland gives way to 'Great Stagnation' worries
2h agoDJMARKET SNAPSHOT : Stronger Dollar Could Put Squeeze On Earnings
3h ago SOFTBANK : estimates $4.6 billion gain from Alibaba listing
Dynamic quotes  
ON
| OFF